Prostaglandin D2receptor antagonists in allergic disorders: safety, efficacy, and future perspectives-Reference-Cited by-同舟云学术

Prostaglandin D2receptor antagonists in allergic disorders: safety, efficacy, and future perspectives

Published:2018-12-07 Issue:1 Volume:28 Page:73-84
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Marone Giancarlo¹²,Galdiero Maria Rosaria³⁴,Pecoraro Antonio³⁴,Pucino Valentina⁵,Criscuolo Gjada³⁴,Triassi Maria¹,Varricchi Gilda³⁴

Affiliation:

1. Department of Public Health, University of Naples Federico II, Naples, Italy

2. Monaldi Hospital Pharmacy, Naples, Italy

3. Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy

4. WAO Center of Excellence, Naples, Italy

5. William Harvey Research Institute, Barts and The London School of Medicine &Dentistry, Queen Mary University of London, London, UK

Funder

Regione Campania CISI-Lab Project, CRèME Projec, and TIMING Project

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1555237

Reference160 articles.

1. New targets for allergic rhinitis — a disease of civilization

2. The immunology of asthma

3. Direct costs of allergic rhinitis in the united states: Estimates from the 1996 medical expenditure panel survey

4. Therapeutic interventions in severe asthma

5. Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in PGD2/PTGDR2 signaling pathway in tumors: A review;Biomolecules and Biomedicine;2024-09-06

2. The prostaglandin D2 antagonist asapiprant ameliorates clinical severity in young hosts infected with invasive Streptococcus pneumoniae;Infection and Immunity;2024-05-07

3. Mast cells: a novel therapeutic avenue for cardiovascular diseases?;Cardiovascular Research;2024-04-17

4. Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma;Journal of Genetic Engineering and Biotechnology;2023-12

5. Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis;European Journal of Internal Medicine;2023-11